Cisatracurium Besylate Injection
Product Images NDC 0781-3150

5 FDA label images from Sandoz Inc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Cisatracurium Besylate (NDC 0781-3150). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sandoz Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical-structure (Cisatracurium Np 01)

Chemical-structure (Cisatracurium Np 01)
Chemical structure of cisatracurium besylate, showing the molecular arrangement including aromatic rings, methoxy groups, ester linkages, and the besylate counter ion represented by the sulfonate group attached to a benzene ring.*
FDA Label Image

Fig-1 (Cisatracurium Np 02)

Fig-1 (Cisatracurium Np 02)
Scatter plot showing variations in heart rate (HR) and mean arterial pressure (MAP) expressed as percentage changes, ranging from -60% to +60%, with clustered data points near the origin. The chart likely depicts cardiovascular response data.*
FDA Label Image

Fig-2 (Cisatracurium Np 03)

Fig-2 (Cisatracurium Np 03)
Scatter plot chart displaying data points representing changes in heart rate (HR) on the vertical axis and mean arterial pressure (MAP) on the horizontal axis, each axis ranging from -60% to +60% change. The chart visually presents variability in HR and MAP percentages without specific numeric labels or context.*
FDA Label Image

5ml-carton (Cisatracurium Np 04)

5ml-carton (Cisatracurium Np 04)
Packaging label for Cisatracurium Besylate Injection, USP 10 mg/5 mL (2 mg/mL) sterile, nonpyrogenic intravenous injection. The label highlights warnings about its paralyzing agent effects and the need for facilities to have artificial respiration available. It specifies a 5 mL single-dose vial and storage instructions at 2°C to 8°C, protected from light. Manufactured by Gland Pharma Limited for Sandoz Inc.*
FDA Label Image

10ml-carton (Cisatracurium Np 05)

10ml-carton (Cisatracurium Np 05)
Packaging label for Cisatracurium Besylate Injection, USP 10 mg/mL (200 mg/20 mL) sterile intravenous injection by Sandoz Inc. The label includes warnings about paralysis and respiratory arrest, directions for ICU use only, storage instructions refrigerated between 2°C to 8°C, and discard information. The label also displays the NDC 0781-3153-80 and the manufacturer Gland Pharma Limited for Sandoz Inc, Princeton, NJ.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.